Olaplex has announced its financial results for the third quarter ended September 30, 2025.
For the three months, net sales decreased 3.8% to $114.6 million (from more than $119 million in 2024). For the nine months, net sales decreased 1.3% to $317.8 million (from $321.9 million in 2024). Net sales decreased 14.6% in the United States and increased 7.1% internationally.
- Specialty retail decreased 13.5% to $36.9 million
- Professional increased 5.3% to $44.5 million
- Direct-to-consumer decreased 2.9% to $33.3 million
In SG&A, three months increased 49.2% to $64.1 million (from $42.9 million in 2024). Adjusted saw a 26.8% increase to $51.2 million (from $40.4 million in 2024). Nine months SG&A saw a 38.2% increase to $178 million, with adjusted SG&A at $149.9 million, marking a 24.7% increase.
Adjusted EBITDA changed 31.0% to $30.8 million from $44.6 million in 2024 for the three months. Nine months saw a 27.8% change to $81 million (2025) from $112.2 million (2024).
As of September 30, 2025, the company had $286.4 million of cash and cash equivalents, compared to $586 million as of December 31, 2024. Inventory at the end of the third quarter of 2025 was $73.3 million, compared to $75.2 million at December 31, 2024.
